[ad_1]
The world peace mission Center of Awareness, a non-governmental organization, has officially launched its well-known dietary product, COA FS, as a dietary supplement and immune stimulant against various autoimmune diseases.
The Center said its product, also called the Awareness Center's nutritional supplement, should continue to be taken solely to strengthen the immune system and not to cure the management and treatment of diseases, particularly HIV and AIDS. Hepatitis B.
The product COA FS is a pure organic food supplement that bioenerises, regenerates and harmonizes immunological cells because it contains phytochemicals, which guarantees its use as a complement in human health.
Launch of the product in Accra, Dr. Samuel Ato Duncan, Executive Chairman of the Peace and Peace Outreach Mission to the Center of Awareness, called on people living with HIV and AIDS not to give up their antiretroviral drugs at taking the COA FS, but taking the latter as an immune booster to speed up the process of repressing viral loads and their CD4 counts.
He said the product had been approved by the Food and Drugs Authority and the Herbal Medicine Research Center, Mampong, as safe.
In addition, various badyzes of the FS COA undertaken by the Noguchi Memorial Medical Research Institute, the Mampong Center for Research in Herbal Medicine, the University of Cape Coast and the KwaZulu-Natal University in Africa South all indicated that the product contained components that: support the immune system that had been compromised by conditions and diseases such as tuberculosis, HIV and hepatitis B.
"COA FS therefore supports the immune system that has not been compromised to resist attacks from harmful foreign organisms such as viruses, bacteria and parasites. It is useful as a supplement for patients receiving orthodox medicines for such diseases. "
Dr. Duncan took the opportunity to announce the new product called COA 72, developed by the Potential HIV / AIDS Prevention Center, and called on science stakeholders to contribute to the development of the drug through scientific protocols. .
He has already said that new research done on COA72 has indicated a dramatic viral suppression of the HIV virus, while further badyzes of its toxicity by renowned institutions have also shown that the drug could potentially treat HIV.
"What we do is complement the work of the Ghana AIDS Commission. We are here for a process that can find lasting solutions for people living with HIV, "said Dr. Duncan.
"What we are saying now is that Ghana should continue work on this product in order to produce appropriate scientific data using the protocols of international standards, to enable the World Health Organization. to accept it for the treatment of HIV and AIDS, "he said. .
Kyeremah Attuahene, Acting Director General of the Ghana AIDS Commission, said that until the introduction of the antiretroviral drug to fight HIV, the Commission had encouraged and supported the use of drugs herbal in hospitals to manage the virus. drug".
He stated that the Commission would like PLHIV to stick to the use of antiretroviral drugs to manage the virus, until the FDA certifies any herbal drug for the treatment of the virus. HIV.
He announced, however, that in May of this year, the Commission had begun working with the Center for Awareness on the possible evaluation of CCO products and the establishment of an activity that could lead to product development.
"That is why, in May of this year, the Commission decided to collaborate with the country's various stakeholders to organize an independent scientific evaluation leading to the development of products" if it is considered effective to treat HIV effectively. .
He added that the lack of funds for drug development, coupled with the Commission's mandate that did not include drug development, prevented it from developing drugs.
But this could play a facilitating role by bringing the relevant institutions together to carry out an independent evaluation of COA's product to determine if they have any activity on HIV-related diseases.
Other speakers included Dr. Kojo Eduful, President of the Federation of Plant Practitioners' Associations of Ghana, Dr. M. Nlooto, Lecturer at the University of KwaZulu-Natal, South Africa, the professor Ben Adu Djan, director of the Noguchi Memorial Medical Research Institute, all reiterated the need for Ghana to partner with the COA producer to develop protocols of relevant international standards that would strengthen the COA 72 as as a cure for HIV.
Dr. Nlooto said that in South Africa, studies conducted by his university had shown that many HIV-positive nationals were using ACO products as their main drug or as supplements to help them to stay alive.
Source: GNA
Source link
